A Bayesian network model has been developed to assess the risk-benefit profile of the Pfizer COVID-19 vaccine in the pediatric population during th...
Since the identification of SARS-CoV-2, vaccine development has progressed rapidly, with 64 vaccines approved globally by February 2024. The develo...
The COVID-19 pandemic has significantly accelerated vaccine development processes, traditionally spanning several years. The rapid progress was ach...
Albert Bourla, the CEO of Pfizer, has been instrumental in the development and distribution of the Pfizer-BioNTech COVID-19 vaccine. Under his lead...
Since the identification of SARS-CoV-2 in January 2020, COVID-19 vaccine development has progressed at an extraordinary pace. Researchers from acad...
Conspiracy theories regarding the origins of COVID-19, particularly the lab leak hypothesis, are hindering efforts to prepare for future pandemics....
AmerisourceBergen has entered into an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to facilitate the distribution of CO...
Ayurvedic medicine, one of the world's oldest medical systems, is based on a holistic approach to health, combining plant-based products, diet, exe...
The spread of misinformation about science is influenced by various factors, including digital communication technologies and social media platform...
The report discusses strategies to address health misinformation, emphasizing the need for a collective effort. It highlights initiatives by truste...